Skip to main content
    M

    Microbot Medical Inc (MBOT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $0.64
    -0.33 (-34.16%)

    Market Cap: $65.73M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Microbot Medical Inc (MBOT) Financials: Revenue, Profit and Cash Flow

    Updated Aug 11, 2026. Financial statements from company filings, amounts in US dollars.

    Microbot Medical reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$13.14M, operating cash flow was -$13.05M and free cash flow was -$13.11M. The quarter ended Jun 30, 2026 had revenue of $241.00K and net income of -$5.63M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $14.74M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0N/AN/AN/AN/A
    Dec 2016$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Research and development$6.28M$6.63M$5.72M$7.74M$6.15M$3.40M$3.05M$2.52M-$1.10M-$901.00K
    Operating income-$14.74M-$11.63M-$9.86M-$13.28M-$11.36M-$9.09M-$7.24M-$7.24M$5.27M$9.63M
    Net income-$13.14M-$11.44M-$10.74M-$13.17M-$11.31M-$9.17M-$7.25M-$7.26M-$2.94M-$9.66M
    EBITDA-$14.38M-$11.53MN/A-$13.18M-$11.28M-$9.02M-$7.06M-$7.19M$5.29M$9.64M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$241.00K$105.00K$0$0$0$0$84.00K$0$0$0$142.00K$0
    Gross profit-$643.00K$2.00K-$10.00K$0$0$0-$26.00K$0$0$0-$35.00K$0
    Operating income-$6.19M-$4.32M-$4.14M-$3.86M-$3.72M-$3.02M-$3.43M-$3.30M-$2.51M-$2.38M-$2.07M-$2.54M
    Net income-$5.63M-$3.67M-$3.46M-$3.58M-$3.50M-$2.60M-$3.39M-$3.21M-$2.46M-$2.37M-$3.15M-$2.45M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $296.00K by $3.62M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$81.54M$6.03M$8.33M$9.54M$16.77M$26.28M$37.13M$6.09M$11.02M$3.37M
    Current assets$79.82M$5.82M$7.92M$8.81M$15.88M$25.25M$35.94M$5.83M$10.93M$3.31M
    Cash and equivalents$3.91M$3.11M$2.47M$2.44M$13.49M$19.65M$28.77M$5.24M$10.79M$2.71M
    Total liabilities$3.99M$2.50M$3.83M$2.25M$2.39M$1.97M$5.59M$4.76M$556.00K$1.17M
    Short-term debt$296.00K$70.00K$191.00K$283.00K$278.00K$187.00K$143.00K$0N/A$76.00K
    Long-term debtN/AN/AN/AN/AN/AN/AN/AN/A$0$76.00K
    Shareholder equity$77.55M$3.53M$4.50M$7.29M$14.38M$24.31M$31.54M$1.33M$9.96M$1.70M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$73.36M$78.07M$81.54M$81.76M$33.13M$30.89M$6.03M$5.21M$7.43M$7.37M$8.33M$8.89M
    Total liabilities$4.44M$3.96M$3.99M$3.54M$2.77M$1.94M$2.50M$1.40M$1.38M$1.20M$3.83M$1.53M
    Cash and equivalents$3.15M$3.66M$3.91M$6.70M$4.08M$3.22M$3.11M$479.00K$2.46M$1.16M$2.47M$1.33M
    Shareholder equity$68.93M$74.11M$77.55M$78.22M$30.36M$28.95M$3.53M$3.81M$6.05M$6.17M$4.50M$7.36M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$13.05M-$8.83M-$8.53M-$11.55M-$9.35M-$7.25M-$6.45M-$5.31M-$4.86M-$786.00K
    Capital expenditures$60.00K$25.00K$33.00K$84.00K$69.00K$91.00K$216.00K$223.00K$58.00K$25.00K
    Free cash flow-$13.11M-$8.85M-$8.57M-$11.63M-$9.42M-$7.34M-$6.67M-$5.53M-$4.91M-$811.00K
    Investing cash flow-$72.38M$1.54M$1.97M-$3.84M$3.20M-$2.77M-$2.45M-$223.00K-$58.00K-$25.00K
    Financing cash flow$86.24M$7.94M$6.56M$4.32M$0-$3.38M$36.77M-$18.00K$13.02M$3.08M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$4.99M-$5.05M-$3.76M-$3.84M-$2.57M-$2.87M-$1.69M-$2.76M-$1.96M-$2.42M-$1.82M-$1.66M
    Capital expenditures$142.00K$108.00K$25.00K$13.00K$9.00K$13.00K$7.00K$0$4.00K$14.00K$5.00K$28.00K
    Free cash flow-$5.13M-$5.16M-$3.78M-$3.85M-$2.58M-$2.89M-$1.70M-$2.76M-$1.96M-$2.43M-$1.83M-$1.68M
    Last 12 quarters

    Frequently Asked Questions About MBOT

    What is Microbot Medical's annual revenue?

    Microbot Medical reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Microbot Medical profitable?

    No. Microbot Medical reported net income of -$13.14M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does MBOT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$13.05M minus capital expenditures of $60.00K produced free cash flow of -$13.11M.

    How much debt does Microbot Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $296.00K and cash and equivalents of $3.91M.